Generalizations of NMDA-receptor antagonists to the discriminative stimulus effects of κ-opioid receptor agonists in rats were examined. Phencyclidine, MK-801, and ketamine, noncompetitive NMDA-receptor antagonists, generalized to the discriminative stimulus effects of U-50,488H, but not those of TRK-820, whereas (±)-3-(2-carbaxypiperazine-4-yl) propyl-1-phosphonic acid (CPP), a competitive NMDA-receptor antagonist, and ifenprodil, an NR1 / NR2B NMDA-receptor antagonist, did not, suggesting that non-competitive NMDA-receptor antagonists possess U-50,488H-like discriminative stimulus effects in rats. Since U-50,488H and phencyclidine both induce aversive effects, our findings indicate that the cue of the discriminative stimulus effects of U-50,488H and non-competitive NMDA-receptor antagonists may be associated with their aversive effects.
It is generally accepted that discriminative stimulus effects of drugs in animals serve as a model for the subjective effects in humans (1) . Furthermore, drug discrimination procedures have been shown to be useful for distinguishing drug effects mediated by κ-opioid receptors from those mediated by other receptors and for characterizing and quantifying such drug-receptor interactions (2 -4) . We recently demonstrated that the patterns of generalization of κ-opioid receptor agonists to the discriminative stimulus effects of other κ-opioid receptor agonists, U-50,488H and TRK-820, were somewhat different (5) . Furthermore, the potency order of κ-opioid receptor agonists to the discriminative stimulus effects of U-50,488H were parallel to the potency of their aversive effects, suggesting that the cue of the discriminative stimulus effects of U-50,488H is related to aversive effects in rats (5) .
Previous reports showed that phencyclidine (PCP), a noncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist, exerts the discriminative stimulus effects in monkeys and rats. κ-Opioid receptor agonists or PCP induce place aversion using place conditioning paradigms (6) . The goal of the present study was to compare the possible similarities in the discriminative stimulus effects of two different types of κ-opioid receptor agonists, U-50,488H and TRK-820, and NMDA-receptor antagonists. Therefore, we examined the generalization of NMDA-receptor antagonists such as PCP, MK-801, ketamine, ifenprodil, and (±)-3-(2-carbaxypiperazine-4-yl)propyl-1-phosphonic acid (CPP) to the discriminative stimulus effects of κ-opioid-receptor agonists in rats.
Sixteen male Fischer 344 rats (Charles River Japan Inc., Atsugi) were maintained at 220 -230 g (80% freefeeding weight). Water was available ad libitum for all of the rats in their home cages. The rats were housed in individual cages at a room temperature of 22 ± 1°C with a 12-h light-dark cycle (light on 8:00 a.m. to 8:00 p.m.).
These studies were conducted in accordance with the Guide for Care and Use of Laboratory Animals of Hoshi University School of Pharmacy and Pharmaceutical Sciences, which is accredited by the Ministry of Education, Culture, Sports, Science and Technology.
Experiments were conducted in operant-conditioning test boxes (Model GT 8810; O'hara & Co., Ltd., Tokyo) equipped with 2 levers and a reinforcement cup mounted midway between the levers. White lamps were installed above each of the levers. Chambers were enclosed within sound-and light-attenuating boxes and supplied with white noise to mask extraneous sound. Reinforcement consisted of a 20-mg food pellet (O'hara & Co., Ltd.).
Before rats were trained to discriminate between cocaine and saline, all rats were trained to press lever. Rats were trained to press either the right or left lever in the daily sequence LRRLLRRLLR (R = right, L = left). Training began under a fixed-ratio (FR) 1 reinforcement schedule in which the rat was presented with a food pellet each time it pressed a lever. When reinforcement was provided, the lamp above the lever was illuminated. After the response rates had stabilized, the FR requirement was steadily increased to a reinforcement schedule of FR 10. After that, the response rates became stabilized under FR 10 and the rat received 40 reinforcements during 4 consecutive sessions; both levers were presented in the chamber. U-50,488H or TRK-820 and saline was administered i.p. 15 min before each session in a daily sequence of SDDSSDDSSD (D = drug, S = saline). Rats were required to respond on the stimulusappropriate lever to obtain reinforcement; there were no programmed consequences for responding on the incorrect lever. Training sessions were 15 min in duration and this phase of training continued until all rats performed up to the required criterion [during 5 consecutive training sessions, at least 83% of the responses that occurred before the first reinforcement (FRF) were made on the correct lever (i.e., FRF ≤12)].
After the animals attained the criterion, the doseresponse and generalization tests were initiated; test sessions were performed after the discrimination criterion described above had been satisfied for at least 3 consecutive sessions; if accuracy criteria were not reached during the training session, rats were trained until their accuracy was maintained for a minimum of 3 training sessions. During the test session, rats were left in the operant box until they had made ten responses on either lever or 5 min had elapsed. In the dose-response tests, rats were tested after the administration of various doses of U-50,488H or TRK-820. In generalization tests, various NMDA-receptor antagonists were tested instead of the training drugs. The pretreatment times and doses of drugs were used: 10 min for 0.5 -2.0 mg / kg PCP and 1.0 -10 mg/ kg ketamine and 30 min for 10 -40 µg/ kg TRK-820, 0.56 -3.0 mg / kg U-50,488H, 10 -80 µg / kg MK-801, 5 -15 mg / kg ifenprodil, and 0.3 -5.6 mg / kg CPP. If the rats did not make 10 responses during each component, the response was judged to have been disrupted.
Drugs were obtained from the following sources:
Research Biochemicals International, Natick, MA, USA); phencyclidine hydrochloride (PCP; Taisho Pharmaceutical Co., Ltd., Ohmiya); 5-methyl-10,11dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate (MK-801, Research Biochemicals International); ketamine hydrochloride (Sigma Chemical Co., St. Louis, MO, USA); (±)-3-(2-carbaxypiperazine-4-yl)propyl-1-phosphonic acid (CPP, Research Biochemicals International); and ifenprodil tartrate (Grelan Pharmaceutical Co., Ltd., Tokyo). TRK-820 was synthesized by us. Ifenprodil was dissolved in 9% Tween 80saline solution at the final concentration of 5% dimethyl sulfoxide. All other drugs were dissolved in saline.
During the training sessions, accuracy was defined in terms of percentage of correct responses out of the total number of responses before the first food pellet. During the test sessions, performance was expressed in terms of the number of drug-appropriate responses as a percentage of the total responses on completion of FR 10. Drugs were considered to have generalized to the discriminative stimulus effects of the training drug if more than 80% of the responses were on the drugappropriate lever. Response rate was calculated by dividing the total number of responses made on either lever by the time (min) to complete the first ratio. The paired Student's t-test was used to compare the response rates during the generalization tests.
Rats required a mean of 23 sessions to acquire the U-50,488-saline discrimination and a mean of 25 sessions to acquire the TRK-820-saline discrimination. Once rats attained the criterion, drug-saline discrimination stabilized and was maintained with a high degree of accuracy.
During the dose-response tests, U-50,488H (1.0 -3.0 mg / kg) and TRK-820 (10 -40 µg / kg) produced a doserelated increase in drug-appropriate responses in all of the rats (Figs. 1A and 2A) , and a significant difference was observed for the response rates in the dose-response tests of U-50,488H (Fig. 1A) . Non-competitive NMDA antagonists such as PCP, MK-801, and ketamine generalized to the discriminative stimulus effects of U-50,488H in a dose-dependent manner, and they decreased response rates when the doses of MK-801 and ketamine were increased. CPP and ifenprodil engendered intermediate levels of U-50,488H-appropriate responding (Fig. 1) , and a significant decrease was observed in the generalization test of CPP at 3.0 mg / mg; however, noted behavioral changes was not observed in the case of 3.0 mg / kg of CPP. The highest doses of ifenprodil (20 mg / kg) and CPP (10 mg / kg) disrupted the responding in the 6 -8 rats out of 8 rats (data not shown). On the other hand, PCP and MK-801 at doses which generalized to the discriminative stimulus effects of U-50,488H, did not generalize to the discriminative stimulus effects of TRK-820 (less than 30% drug-appropriate responding) (Fig. 2) . Saline did not engender drug-appropriate responses with mean response rate between 45 and 75 (responses / min) ( Figs.  1 and 2) . Our previous study demonstrated that U-50,488H generalizes to the discriminative stimulus effects of TRK-820, whereas TRK-820 did not generalize to those of U-50,488H, indicating that the discriminative stimulus effects of TRK-820 and U-50,488H were somewhat different (5) . In the generalization tests using κ-opioid receptor agonists, E-2078, but not R-84760, generalized to the discriminative stimulus effects of both TRK-820 and U-50,488H, whereas KT-90, CI-977, and ICI-199441 generalized to the discriminative stimulus effects of U-50,488H, but not to those of TRK-820 (5) . Thus, the patterns of generalization with various κopioid receptor agonists to the discriminative stimulus effects of U-50,488H and TRK-820 were different. These results and the present data indicate that there are qualitative differences between the discriminative stimulus effects of TRK-820 and U-50,488H (5) . In the present study, we demonstrated that non-competitive NMDA-receptor antagonists including PCP, MK-801 and ketamine generalized to the discriminative stimulus effects of U-50,488H. On the other hand, these noncompetitive NMDA-receptor agonists did not generalize to the discriminative stimulus effects of TRK-820. These results suggest that these non-competitive NMDA-receptor antagonists possess the U-50,488Hlike discriminative stimulus effects in rats. TRK-820 failed to produce a significant place aversion in rodents at doses that were sufficient to produce significant place aversion (7, 8) and induced place aversion only at high doses (9) . The ability of opioids to produce the discriminative stimulus effects is believed to be homologous to the subjective effects that opioids produce in humans. It has been reported that κ-opioid receptor agonists produce dysphoria and psychotomimetic effects in humans (10, 11) and aversive effects in rodents (12 -14) . These results may support our hypothesis that the cue of the discriminative stimulus effects of U-50,488H may be associated with aversive effects in rats, and the cue of the discriminative stimulus effects of U-50,488H and some NMDA-receptor antagonists may be, at least in part, accompanied by their aversive effects.
It was reported that PCP failed to generalize to the discriminative stimulus effects of a κ-opioid receptor agonist, U62,066, in rats (15) and that PCP partially generalized to the discriminative stimulus effects of U-50,488H (about 40% drug-lever responding) (16) . In the present study, PCP generalized to the discriminative stimulus effects of U-50,488H. With regard to these results, it is known that pretreatment time is especially important for enabling a drug to exert discriminative stimulus effects. The previous studies on incomplete generalization of PCP to the discriminative stimulus effects of κ-opioid receptor agonists were performed after a longer (30 min) pretreatment time (16) than that used in the present study (10 min). Therefore, treatment time may explain why PCP and other NMDA-related compounds generalized to the discriminative stimulus effects of U-50,488H in the present study.
In rats discriminating PCP from saline, MK-801 and ketamine, but not CPP and ifenprodil, generalized to the discriminative stimulus effects of PCP (17 -19) . The present study showed the lack of generalization of the competitive NMDA-receptor antagonist CPP and an antagonist of the NMDA-associated polyamine site ifenprodil to the discriminative stimulus effects of U-50,488H. Furthermore, PCP induces place aversion (6) , whereas ifenprodil did not produce either place preference or aversion using place conditioning paradigms (20) . These findings provide further evidence that there are subtle differences between non-competitive and competitive NMDA-receptor antagonists on the discriminative stimulus effects. Furthermore, to strengthen our hypothesis that there are differences between the discriminative stimulus effects of TRK-820 and U-50,488H, further examinations are needed, especially generalization tests of other NMDA-receptor antagonists to the discriminative stimulus effects of TRK-820.
In summary, the results of the present study showed that qualitative differences exist between the discriminative stimulus effects of U-50,488H and TRK-820, and NMDA-receptor antagonists, such as PCP, MK-801, and ketamine, possess U-50,488H-like discriminative stimulus effects in rats. The mechanism underlying the generalization of NMDA-receptor antagonists used in the present study for the discriminative stimulus effects of U-50,488H remains unclear. However, these findings suggest the possibility that the cue of the discriminative stimulus effects of U-50,488H may be, at least in part, associated with its aversive effects.
